Inke in Numbers: Innovation that Drives Long-Term Value

At Inke, innovation is not just a goal — it is a strategic pillar that guides our growth and strengthens our partnerships. Our patent portfolio stands as tangible proof of this commitment. Over the past two decades, we have consistently developed and protected advanced synthesis processes and optimized micronization techniques that enhance both the performance and manufacturability of pharmaceutical active pharmaceutical ingredients (APIs).

Today, Inke offers over 35 commercial APIs, with an additional 13 APIs currently in our development pipeline. This reflects our sustained investment in R&D and our dedication to expanding therapeutic options for our partners around the world.

Our patents in numbers:

• 120 granted patents worldwide

• 20 active patent applications in key markets

• 3 new international filings every year

These figures represent more than intellectual property — they reflect our determination to deliver differentiated, high-value solutions that support technical excellence and regulatory confidence.

Our protected technologies enable us to offer enhanced control over critical quality attributes, including particle size distribution, solubility, and stability — factors that are fundamental to the success of inhalation APIs and the treatments they support.

At Inke, we believe that transforming scientific know-how into practical solutions is what creates a true competitive advantage — for us, for our partners, and ultimately for patients.